Tech Company Financing Transactions

Adarza BioSystems Funding Round

On 3/22/2016, Adarza BioSystems secured $5 million in Series B investment from Cultivation Capital, Lewis & Clark Ventures and Siemens Venture Capital.

Transaction Overview

Company Name
Announced On
3/22/2016
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series B
Investors

Cultivation Capital (Lead Investor) (David Smoller)

Lewis & Clark Ventures (Brian Hopcraft)

Siemens Venture Capital (Ralf Schnell)

Proceeds Purpose
Proceeds from the financing will be used to expand production capacity in its St. Peters, MO manufacturing facility and launch its first immunoassay product consumable and instrument platform. Proceeds will also be used to accelerate development of highly sensitive assays targeting a variety of biological analytes including cytokines, antigens and small molecules.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2184 Welsch Industrial Ct.
St. Louis, MO 63146
USA
Email Address
Overview
Adarza BioSystems develops a biological assay platform for measuring clinical and point-of-care samples.
Profile
Adarza BioSystems LinkedIn Company Profile
Social Media
Adarza BioSystems Company Twitter Account
Company News
Adarza BioSystems News
Facebook
Adarza BioSystems on Facebook
YouTube
Adarza BioSystems on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Bryan Witherbee
  Bryan Witherbee LinkedIn Profile  Bryan Witherbee Twitter Account  Bryan Witherbee News  Bryan Witherbee on Facebook
VP - Bus. Development
Linda Meeh
  Linda Meeh LinkedIn Profile  Linda Meeh Twitter Account  Linda Meeh News  Linda Meeh on Facebook
VP - Engineering
Jason Mitchell
  Jason Mitchell LinkedIn Profile  Jason Mitchell Twitter Account  Jason Mitchell News  Jason Mitchell on Facebook
VP - Engineering
Randy Motluck
  Randy Motluck LinkedIn Profile  Randy Motluck Twitter Account  Randy Motluck News  Randy Motluck on Facebook
VP - Engineering
Christopher Striemer
  Christopher Striemer LinkedIn Profile  Christopher Striemer Twitter Account  Christopher Striemer News  Christopher Striemer on Facebook
VP - Finance
Nakul Tandon
  Nakul Tandon LinkedIn Profile  Nakul Tandon Twitter Account  Nakul Tandon News  Nakul Tandon on Facebook
VP - Manufacturing
Bob Crepin
  Bob Crepin LinkedIn Profile  Bob Crepin Twitter Account  Bob Crepin News  Bob Crepin on Facebook
VP - R & D
Jon Schmuke
  Jon Schmuke LinkedIn Profile  Jon Schmuke Twitter Account  Jon Schmuke News  Jon Schmuke on Facebook
VP - Regulatory Affairs
Nannette Langevin
  Nannette Langevin LinkedIn Profile  Nannette Langevin Twitter Account  Nannette Langevin News  Nannette Langevin on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/22/2016: eGym venture capital transaction
Next: 3/22/2016: Replyapp.io venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary